Stoneridge Investment Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-10,103
| Closed | -$99K | – | 314 |
|
|
2017
Q2 | $99K | Sell |
10,103
-15,219
| -60% | -$149K | 0.01% | 237 |
|
|
2017
Q1 | $614K | Sell |
25,322
-2,874
| -10% | -$69.7K | 0.08% | 208 |
|
|
2016
Q4 | $905K | Hold |
28,196
| – | – | 0.12% | 186 |
|
|
2016
Q3 | $1.41M | Buy |
28,196
+5,250
| +23% | +$262K | 0.2% | 150 |
|
|
2016
Q2 | $973K | Hold |
22,946
| – | – | 0.15% | 175 |
|
|
2016
Q1 | $1.51M | Sell |
22,946
-3,527
| -13% | -$232K | 0.22% | 127 |
|
|
2015
Q4 | $1.65M | Buy |
26,473
+11,073
| +72% | +$688K | 0.22% | 125 |
|
|
2015
Q3 | $1.03M | Buy |
15,400
+6,374
| +71% | +$427K | 0.14% | 156 |
|
|
2015
Q2 | $878K | Sell |
9,026
-697
| -7% | -$67.8K | 0.11% | 175 |
|
|
2015
Q1 | $909K | Sell |
9,723
-8,896
| -48% | -$832K | 0.11% | 181 |
|
|
2014
Q4 | $1.66M | Sell |
18,619
-35,522
| -66% | -$3.16M | 0.22% | 133 |
|
|
2014
Q3 | $3.74M | Buy |
54,141
+4,441
| +9% | +$307K | 0.55% | 61 |
|
|
2014
Q2 | $2.85M | Buy |
49,700
+38,477
| +343% | +$2.21M | 0.43% | 77 |
|
|
2014
Q1 | $445K | Buy |
11,223
+607
| +6% | +$24.1K | 0.09% | 131 |
|
|
2013
Q4 | $445K | Hold |
10,616
| – | – | 0.09% | 129 |
|
|
2013
Q3 | $317K | Buy |
+10,616
| New | +$317K | 0.07% | 150 |
|